• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-93介导的DAB2下调定义了肺癌中的一种新致癌途径。

miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.

作者信息

Du L, Zhao Z, Ma X, Hsiao T-H, Chen Y, Young E, Suraokar M, Wistuba I, Minna J D, Pertsemlidis A

机构信息

1] Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA [2] Department of Cellular and Structural Biology, UT Health Science Center at San Antonio, San Antonio, TX, USA.

Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA.

出版信息

Oncogene. 2014 Aug 21;33(34):4307-15. doi: 10.1038/onc.2013.381. Epub 2013 Sep 16.

DOI:10.1038/onc.2013.381
PMID:24037530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4281941/
Abstract

The disabled homolog 2 (DAB2) gene was recently identified as a tumor suppressor gene with its expression downregulated in multiple cancer types. The role of DAB2 in lung tumorigenesis, however, is not fully characterized, and the mechanisms of DAB2 dysregulation in lung cancer are not defined. Here we show that low DAB2 levels in lung tumor specimens are significantly correlated with poor patient survival, and that DAB2 overexpression significantly inhibits cell growth in cultured lung cancer cells, indicating its potent tumor suppressor function. We next identify that microRNA miR-93 functions as a potent repressor of DAB2 expression by directly targeting the 3'UTR of the DAB2 mRNA. Using in vitro and in vivo approaches, we demonstrate that miR-93 overexpression has an important role in promoting lung cancer cell growth, and that its oncogenic function is primarily mediated by downregulating DAB2 expression. Our clinical investigations further indicate that high tumor levels of miR-93 are correlated with poor survival of lung cancer patients. The correlations of both low DAB2 and high miR-93 expression levels with poor patient survival strongly support the critical role of the miR-93/DAB2 pathway in determining lung cancer progression.

摘要

失能同源物2(DAB2)基因最近被鉴定为一种肿瘤抑制基因,其在多种癌症类型中的表达下调。然而,DAB2在肺癌发生中的作用尚未完全阐明,肺癌中DAB2失调的机制也不明确。在此,我们发现肺癌组织标本中DAB2水平较低与患者预后不良显著相关,并且DAB2过表达显著抑制培养的肺癌细胞的生长,表明其具有强大的肿瘤抑制功能。接下来,我们确定微小RNA miR-93通过直接靶向DAB2 mRNA的3'UTR发挥对DAB2表达的有效抑制作用。利用体外和体内实验方法,我们证明miR-93过表达在促进肺癌细胞生长中起重要作用,并且其致癌功能主要通过下调DAB2表达介导。我们的临床研究进一步表明,肺癌患者肿瘤中miR-93水平较高与患者预后不良相关。DAB2水平低和miR-93表达水平高均与患者预后不良相关,这有力地支持了miR-93/DAB2通路在决定肺癌进展中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/cdaf5de88559/nihms560248f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/2a3fa1c2d8ae/nihms560248f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/7b698a445fc2/nihms560248f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/0333a12d35d1/nihms560248f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/40105e119ba7/nihms560248f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/140ee9e913e7/nihms560248f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/417b7ed4c217/nihms560248f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/498c007b89f3/nihms560248f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/30faf43b846e/nihms560248f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/ee8e6d6619dd/nihms560248f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/cdaf5de88559/nihms560248f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/2a3fa1c2d8ae/nihms560248f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/7b698a445fc2/nihms560248f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/0333a12d35d1/nihms560248f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/40105e119ba7/nihms560248f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/140ee9e913e7/nihms560248f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/417b7ed4c217/nihms560248f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/498c007b89f3/nihms560248f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/30faf43b846e/nihms560248f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/ee8e6d6619dd/nihms560248f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de30/4281941/cdaf5de88559/nihms560248f10.jpg

相似文献

1
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.miR-93介导的DAB2下调定义了肺癌中的一种新致癌途径。
Oncogene. 2014 Aug 21;33(34):4307-15. doi: 10.1038/onc.2013.381. Epub 2013 Sep 16.
2
Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.microRNA-187 通过靶向Disabled 同源物-2 调控卵巢癌进展。
Oncogene. 2012 Feb 9;31(6):764-75. doi: 10.1038/onc.2011.269. Epub 2011 Jul 4.
3
miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.miR-191/DAB2 轴调控雌激素受体阳性乳腺癌的致瘤性。
IUBMB Life. 2018 Jan;70(1):71-80. doi: 10.1002/iub.1705. Epub 2017 Dec 16.
4
MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.微小RNA-34c-3p通过调控NCKAP1表达促进肝细胞癌的细胞增殖和侵袭。
J Cancer Res Clin Oncol. 2017 Feb;143(2):263-273. doi: 10.1007/s00432-016-2280-7. Epub 2016 Oct 4.
5
MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.微小RNA-106b通过靶向宫颈癌中的失活同源物2参与转化生长因子β1诱导的细胞迁移。
J Exp Clin Cancer Res. 2016 Jan 15;35:11. doi: 10.1186/s13046-016-0290-6.
6
Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.抑癌基因 DAB2 异常甲基化和表达下调促进肺癌的发生。
Int J Oncol. 2013 Nov;43(5):1636-42. doi: 10.3892/ijo.2013.2084. Epub 2013 Aug 29.
7
MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.miR-93 通过靶向Disabled homolog 2 (DAB2) 和绿茶(Camellia sinensis)中的一种抗肿瘤多糖来发挥其在前列腺癌中的肿瘤促进作用。
Int J Biol Macromol. 2019 Mar 15;125:557-565. doi: 10.1016/j.ijbiomac.2018.12.088. Epub 2018 Dec 10.
8
MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.微小RNA-194在结直肠癌中通常受到抑制,它通过调节丝裂原活化蛋白激酶4激酶4/ c-Jun/小鼠双微体2信号通路来抑制肿瘤生长。
Cell Cycle. 2015;14(7):1046-58. doi: 10.1080/15384101.2015.1007767.
9
MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.微小 RNA-100 是非小细胞肺癌的潜在分子标志物,通过靶向 Polo 样激酶 1 发挥肿瘤抑制作用。
BMC Cancer. 2012 Nov 14;12:519. doi: 10.1186/1471-2407-12-519.
10
Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.抑癌基因 DAB2 常因启动子甲基化而在鼻咽癌中下调。
BMC Cancer. 2010 Jun 3;10:253. doi: 10.1186/1471-2407-10-253.

引用本文的文献

1
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.对SAFIR02-Lung队列中的肺腺癌进行分子分析,发现了新的与转移相关的拷贝数改变,包括频繁出现的突变特异性KRAS等位基因失衡,并确定CDKN2A纯合缺失是预后不良的独立生物标志物。
Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03183-2.
2
Identification of proteins' expression pathway and the effective miRNAs for the treatment of human papillomavirus-induced cervical cancer: in-silico analyses-experimental research.鉴定蛋白质表达途径及用于治疗人乳头瘤病毒诱导的宫颈癌的有效微小RNA:计算机模拟分析-实验研究
Ann Med Surg (Lond). 2024 Aug 30;86(10):5784-5792. doi: 10.1097/MS9.0000000000002513. eCollection 2024 Oct.
3

本文引用的文献

1
MiR-93 enhances angiogenesis and metastasis by targeting LATS2.miR-93 通过靶向 LATS2 促进血管生成和转移。
Cell Cycle. 2012 Dec 1;11(23):4352-65. doi: 10.4161/cc.22670. Epub 2012 Oct 30.
2
Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage.肺癌中无调谐同源物 1 的表达与 Wnt 通路抑制剂以及分化和原发性肿瘤分期相关。
APMIS. 2013 Feb;121(2):111-9. doi: 10.1111/j.1600-0463.2012.02946.x. Epub 2012 Jul 4.
3
Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer.
Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer.Disabled-2:一种由高分子量透明质酸上调的蛋白,在卵巢癌中具有促进肿瘤和抑制肿瘤的双重作用。
Cell Mol Life Sci. 2023 Oct 10;80(11):320. doi: 10.1007/s00018-023-04972-9.
4
MiRNA-93: a novel signature in human disorders and drug resistance.miRNA-93:人类疾病和耐药性的新型标志物。
Cell Commun Signal. 2023 Apr 19;21(1):79. doi: 10.1186/s12964-023-01106-3.
5
Disabled-2 (): A Key Regulator of Anti- and Pro-Tumorigenic Pathways.Disabled-2():抑癌和促癌途径的关键调节因子。
Int J Mol Sci. 2022 Dec 31;24(1):696. doi: 10.3390/ijms24010696.
6
Fumarate hydratase inhibits non-small cell lung cancer metastasis via inactivation of AMPK and upregulation of DAB2.延胡索酸水合酶通过使AMPK失活和上调DAB2来抑制非小细胞肺癌转移。
Oncol Lett. 2022 Dec 9;25(1):42. doi: 10.3892/ol.2022.13627. eCollection 2023 Jan.
7
MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential.肺癌中的微小RNA:诊断、预后及治疗潜力
Diagnostics (Basel). 2022 Jul 1;12(7):1610. doi: 10.3390/diagnostics12071610.
8
Preliminary construction of a regulatory network of miRNAs in the pathogenesis of nucleus pulposus degeneration - a review based on data mining.基于数据挖掘的髓核退变发病机制中miRNA调控网络的初步构建——综述
Am J Transl Res. 2021 Sep 15;13(9):9919-9931. eCollection 2021.
9
MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.MicroRNA-93 敲低通过上调 DAB2 使 PI3K/AKT 通路失活来抑制急性髓系白血病细胞生长。
Int J Oncol. 2021 Oct;59(4). doi: 10.3892/ijo.2021.5260. Epub 2021 Sep 3.
10
Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma.结直肠癌和胰腺导管癌转移的治疗方法
Pharmaceutics. 2021 Jan 14;13(1):103. doi: 10.3390/pharmaceutics13010103.
非小细胞肺癌患者恶性胸腔积液中游离 microRNA 表达谱与患者生存的关系。
PLoS One. 2012;7(8):e43268. doi: 10.1371/journal.pone.0043268. Epub 2012 Aug 24.
4
miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers.miR-337-3p 及其靶基因 STAT3 和 RAP1A 调节非小细胞肺癌对紫杉烷类药物的敏感性。
PLoS One. 2012;7(6):e39167. doi: 10.1371/journal.pone.0039167. Epub 2012 Jun 18.
5
miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.微小RNA-93/106b及其宿主基因MCM7在平滑肌瘤中差异表达,且在功能上靶向F3和白细胞介素-8。
Mol Endocrinol. 2012 Jun;26(6):1028-42. doi: 10.1210/me.2012-1075. Epub 2012 May 3.
6
miR-93/Sp7 function loop mediates osteoblast mineralization.miR-93/Sp7 功能循环介导成骨细胞矿化。
J Bone Miner Res. 2012 Jul;27(7):1598-606. doi: 10.1002/jbmr.1621.
7
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.微小 RNA-93 通过调控 PTEN/Akt 信号通路参与调节卵巢癌细胞对化疗药物顺铂的敏感性。
FEBS Lett. 2012 May 7;586(9):1279-86. doi: 10.1016/j.febslet.2012.03.006. Epub 2012 Mar 27.
8
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.miR-106b-25 簇靶向 Smad7,激活 TGF-β 信号通路,并在人类乳腺癌中 Six1 下游诱导 EMT 和肿瘤起始细胞特征。
Oncogene. 2012 Dec 13;31(50):5162-71. doi: 10.1038/onc.2012.11. Epub 2012 Jan 30.
9
Rapid generation of microRNA sponges for microRNA inhibition.快速生成 microRNA 海绵以抑制 microRNA。
PLoS One. 2012;7(1):e29275. doi: 10.1371/journal.pone.0029275. Epub 2012 Jan 6.
10
Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs.弱的种子配对稳定性和高的靶标位点丰度降低了 lsy-6 和其他 microRNAs 的效率。
Nat Struct Mol Biol. 2011 Sep 11;18(10):1139-46. doi: 10.1038/nsmb.2115.